Comparison of the Therapeutic Effects of Intra-Articular Injection of Ozone and Corticosteroid in Knee Osteoarthritis - Trial NCT06328270
Access comprehensive clinical trial information for NCT06328270 through Pure Global AI's free database. This phase not specified trial is sponsored by Sisli Hamidiye Etfal Training and Research Hospital and is currently Completed. The study focuses on Knee Osteoarthritis. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sisli Hamidiye Etfal Training and Research Hospital
Timeline & Enrollment
N/A
Sep 01, 2020
Mar 30, 2022
Primary Outcome
Visual Pain Score,Western Ontario and McMaster Universities Arthritis Index
Summary
This clinical trial aimed to involve patients aged 40-85 years who had been experiencing knee
 pain for at least 6 months and had received a clinical diagnosis of knee osteoarthritis
 through radiologic imaging. The patients were randomly assigned to two groups. One group
 received a 3-week intra-articular injection of 15 mg/ml ozone, while the second group
 received a 1 ml intra-articular injection of betamethasone. All patients were evaluated
 before treatment, as well as 4 and 12 weeks after the first dose of treatment. The study
 evaluated treatment efficacy using the Visual Pain Score (VAS) and the Western Ontario and
 McMaster Universities Arthritis Index (WOMAC).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06328270
Non-Device Trial